SPY420.86+5.94 1.43%
DIA338.78+5.82 1.75%
IXIC14,141.48+111.10 0.79%

BRIEF-Xenon Pharmaceuticals Reports Qtrly Loss Per Share 42 Cents

05/11/2021 16:28
BRIEF-Xenon Pharmaceuticals Reports Qtrly Loss Per Share 42 Cents

- Xenon Pharmaceuticals Inc XENE.O:

  • XENON PHARMACEUTICALS REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

  • Q1 REVENUE $4.4 MILLION VERSUS $7.1 MILLION

  • Q1 REVENUE ESTIMATE $3 MILLION -- REFINITIV IBES DATA

  • TOPLINE DATA FROM XEN1101 PHASE 2B "X-TOLE" CLINICAL TRIAL ANTICIPATED BY END OF Q3 OF 2021

  • QTRLY LOSS PER SHARE 42 CENTS

  • Q1 EARNINGS PER SHARE VIEW $-0.43 -- REFINITIV IBES DATA

Source text for Eikon: ID:nGNX3sNtvJ

Further company coverage: XENE.O


(([email protected]s.com;))